Loading organizations...
§ Private Profile · 156 Great Charles St Queensway, Birmingham, West Midlands, B3 3HN, United Kingdom
Biomedical technology company develops smart, wearable devices for lower-limb prosthesis fitting, focused on the INSIGHT system.
Adapttech is a biomedical technology company based in Birmingham, United Kingdom, and Porto, Portugal, that develops smart wearable devices and software to improve the fitting process for lower-limb prostheses. The enterprise provides orthotics and prosthetics clinics with its FDA-certified INSIGHT system, which combines three-dimensional scanning, wearable sensors, and software-as-a-service subscriptions for clinical data analysis. Operating with an estimated workforce of 15 to 50 employees, the medical technology firm has raised more than €5 million in total venture funding to date. This capitalization includes a €2.3 million investment round closed in 2021 to fund commercial expansion, backed by institutional investors such as Bionova Capital, Mercia Asset Management, ACF Investors, and Wren Capital. In 2022, the business expanded its hardware portfolio by launching the INSIGHT Digitizer. Adapttech was founded in 2015 by Frederico Carpinteiro and Mario Saenz Espinoza.
Adapttech has raised $7.5M across 3 funding rounds.
Adapttech has raised $7.5M in total across 3 funding rounds.
Adapttech is a biomedical innovation company founded in 2015 that develops smart, wearable technologies for the orthotics and prosthetics (O&P) industry, focusing on remote patient monitoring for lower-limb prosthetic users.[1][2][6] Its key products, like the INSIGHT Range, provide data-driven solutions to O&P clinics and insurance companies, aiding clinical decision-making and improving patient outcomes for those with physical limitations.[1][2] The company serves healthcare providers, prosthetists, rehabilitation centers, and patients, addressing challenges in prosthetic care such as monitoring and optimization; it has raised $7.33M total, with its latest Series C round of ~$2.9M in 2022 from investors including Mercia Asset Management, ACF Investors, Wren Capital, Wealth Club, and Bionova Capital, signaling steady growth before its acquisition.[1][2]
In April (year not specified in sources, but post-2022 funding), Amparo, a direct-fit prosthetic socket manufacturer, acquired Adapttech to integrate its smart tech with socket solutions, creating a holistic prosthetic care approach for better comfort and function; post-acquisition, Adapttech's former CEO Frederico Carpinteiro became Amparo's CEO.[4]
Adapttech was founded in 2015 in Birmingham, England, at the Institute of Translational Medicine, by Dr. Edward Haeggström, a Finnish physicist with a Ph.D. from the University of Helsinki and an MBA in innovation management.[1] Haeggström, born in 1969, brought commercial experience from roles at Dr. Reddy's (Head of Asia Pacific Sales), Prosonix Ltd (global business development), and prior sales positions, driving the company's focus on biomedical tech for O&P.[1] The idea emerged from a need for remote monitoring in prosthetics, leading to early traction via products that empower clinics with patient data; pivotal funding included a £2.25M (~$2.9M) round in April 2022, supporting commercial expansion amid market presence.[1][2][8] This culminated in its acquisition by Amparo on April 2 (year unspecified), merging teams and leadership for scaled impact.[4]
Adapttech rides the wave of digital health and medtech innovation in O&P, where aging populations and rising limb loss rates (from diabetes, trauma) drive demand for smart, data-driven prosthetics amid a market favoring remote monitoring post-COVID.[1][2][8] Timing aligns with regulatory pushes for outcome-based care and insurer adoption of tech for cost savings; market forces like wearable sensor advancements and AI analytics favor its solutions over static prosthetics.[1][4] By merging with Amparo, it influences the ecosystem toward integrated "prosthetic ecosystems," boosting UK/EU medtech hubs like Birmingham and accelerating adoption in rehab, potentially setting standards for holistic care.[1][2][4]
Post-acquisition, Adapttech's tech will likely fuel Amparo's growth under new CEO Frederico Carpinteiro, expanding the INSIGHT Range globally and tackling execution risks in sales penetration.[2][4][8] Trends like AI-enhanced prosthetics, regulatory streamlining for wearables, and insurer data mandates will shape its path, evolving influence from niche innovator to ecosystem leader in personalized O&P care. As medtech consolidates, this merger positions it to redefine mobility for millions, building on its biomedical roots to deliver scalable, life-changing tech.[1][4]
Adapttech has raised $7.5M in total across 3 funding rounds.
Adapttech's investors include ACF Investors, Stephen Windsor, Alex Davies, Bionova Capital, Mercia, Wealth Club, Wren Capital.
Adapttech has raised $7.5M across 3 funding rounds. Most recently, it raised $3.0M Series A in April 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Apr 1, 2022 | $3M Series A | — | ACF Investors, Stephen Windsor, Alex Davies | Announced |
| Mar 23, 2021 | $2.8M Venture Round | — | ACF Investors, Bionova Capital, Mercia, Wealth Club, Wren Capital | Announced |
| Oct 15, 2018 | $1.7M Venture Round | — | Bionova Capital, Mercia | Announced |